SWTX SpringWorks Therapeutics, Inc.: institutional ownership and insider trading
5 funds reported holding $7.85M of SpringWorks Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $0, with 0 new positions and 0 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market; over its last four quarters it reported revenue of $220M and net income of −$254M.
SWTX revenue and earnings
- Quarter ended Mar 31, 2025: revenue $49.1M, net income −$83.2M, EPS -1.11
- Quarter ended Dec 31, 2024: revenue $61.5M, net income −$77.3M, EPS -1.04
- Quarter ended Sep 30, 2024: revenue $49.3M, net income −$53.5M, EPS -0.72
- Quarter ended Jun 30, 2024: revenue $59.7M, net income −$39.9M, EPS -0.54
Largest institutional holders of SWTX
- Nuveen Asset Management, LLC — $6.64M
- Orion Portfolio Solutions, LLC — $1.19M
- Lindbrook Capital, LLC — $10.9K
- First Horizon Advisors, Inc. — $2.73K
- HUNTINGTON NATIONAL BANK — $47
Recent SWTX insider trades
- Mar 3, 2025: Islam Saqib sold 49,000 shares ($2.66M)
- Mar 3, 2025: Edris Badreddin sold 20,000 shares ($1.08M)
- Feb 20, 2025: Lynch Daniel sold 47,600 shares ($2.87M)
- Feb 20, 2025: Ashar Bhavesh sold 1,016 shares ($62.2K)
Members of Congress trading SWTX
- Jul 2, 2025: Josh Gottheimer sold $1.00K–$15.0K
- Jul 1, 2025: Gilbert Ray Cisneros, Jr. sold $15.0K–$50.0K
- Jan 29, 2025: Gilbert Ray Cisneros, Jr. bought $1.00K–$15.0K
- Jul 19, 2024: Josh Gottheimer bought $1.00K–$15.0K
- Jun 18, 2024: Josh Gottheimer sold $1.00K–$15.0K
- May 9, 2024: Josh Gottheimer bought $1.00K–$15.0K
5%+ owners
- The Vanguard Group: 9.6% (Schedule 13G/A, filed Jan 31, 2025)
- Hudson Bay Capital Management LP: 5.2% (Schedule 13G, filed Aug 8, 2025)
Who owns the most SWTX stock?
The largest institutional holders of SpringWorks Therapeutics, Inc. in the latest 13F filings are Nuveen Asset Management, LLC ($6.64M), Orion Portfolio Solutions, LLC ($1.19M), Lindbrook Capital, LLC ($10.9K).
Are insiders buying or selling SWTX?
No open-market insider buys or sells of SpringWorks Therapeutics, Inc. were reported in the last 12 months.
What was SWTX's revenue last quarter?
SpringWorks Therapeutics, Inc. reported revenue of $49.1M for the quarter ended March 31, 2025, with net income of −$83.2M.